Improving expression of recombinant human IGF-1 using IGF-1R knockout CHO cell lines

被引:11
作者
Romand, Sandrine [1 ]
Jostock, Thomas [1 ]
Fornaro, Mara [2 ]
Schmidt, Joerg [3 ]
Ritter, Anett [1 ]
Wilms, Burkhard [1 ]
Laux, Holger [1 ]
机构
[1] Novartis Pharmaceut, Integrated Biol Profiling, Klybeckstr 141, CH-4057 Basel, Switzerland
[2] Novartis Inst BioMed Res, Musculoskeletal Dis, Basel, Switzerland
[3] Novartis Pharmaceut, Cell & Gene Therapies, Basel, Switzerland
关键词
CHO; IGF-1; IGF-1R; cell line engineering; ZFN; Chinese hamster ovary; GROWTH-FACTOR-I; MONOCLONAL-ANTIBODY PRODUCTION; SOMATIC MAMMALIAN CELLS; HAMSTER OVARY CELLS; PROTEIN THERAPEUTICS; INSULIN; RECEPTOR; APOPTOSIS; GENES; CULTIVATION;
D O I
10.1002/bit.25877
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Chinese Hamster Ovary (CHO) cells are widely used for the large-scale production of recombinant biopharmaceuticals. However, attempts to express IGF-1 (a mutated human Insulin-like growth factor 1 Ea peptide (hIGF-1Ea mut)) in CHO cells resulted in poor cell growth and low productivity (0.1-0.2g/L). Human IGF-1 variants negatively impacted CHO cell growth via the IGF-1 receptor (IGF-1R). Therefore knockout (KO) of the IGF-1R gene in two different CHO cell lines as well as knockdown (KD) of IGF-1R in one CHO cell line were performed. These cell line engineering approaches decreased significantly the hIGF-1 mediated cell growth inhibition and increased productivity of both KO CHO cell lines as well as of the KD CHO cell line. A productivity increase of 10-fold at pool level and sevenfold at clone level was achieved, resulting in a titer of 1.3g/L. This data illustrate that cell line engineering approaches are powerful tools to improve the yields of recombinant proteins which are difficult to produce in CHO cells. Biotechnol. Bioeng. 2016;113: 1094-1101. (c) 2015 Wiley Periodicals, Inc.
引用
收藏
页码:1094 / 1101
页数:8
相关论文
共 47 条
[1]   Insulin and IGF-1 mediated inhibition of apoptosis in CHO cells grown in suspension in a protein-free medium [J].
Adamson, Lars ;
Walum, Erik .
ATLA-ALTERNATIVES TO LABORATORY ANIMALS, 2007, 35 (03) :349-352
[2]   Life and death in mammalian cell culture: strategies for apoptosis inhibition [J].
Arden, N ;
Betenbaugh, MJ .
TRENDS IN BIOTECHNOLOGY, 2004, 22 (04) :174-180
[3]   The I-CreI meganuclease and its engineered derivatives: applications from cell modification to gene therapy [J].
Arnould, S. ;
Delenda, C. ;
Grizot, S. ;
Desseaux, C. ;
Paques, F. ;
Silva, G. H. ;
Smith, J. .
PROTEIN ENGINEERING DESIGN & SELECTION, 2011, 24 (1-2) :27-31
[4]  
Barton ER, 2006, APPL PHYSIOL NUTR ME, V31, P791, DOI [10.1139/H06-054, 10.1139/h06-054]
[5]   Antibody production [J].
Birch, John R. ;
Racher, Andrew J. .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (5-6) :671-685
[6]   Chinese hamster genome sequenced from sorted chromosomes [J].
Brinkrolf, Karina ;
Rupp, Oliver ;
Laux, Holger ;
Kollin, Florian ;
Ernst, Wolfgang ;
Linke, Burkhard ;
Kofler, Rudolf ;
Romand, Sandrine ;
Hesse, Friedemann ;
Budach, Wolfgang E. ;
Galosy, Sybille ;
Mueller, Dethardt ;
Noll, Thomas ;
Wienberg, Johannes ;
Jostock, Thomas ;
Leonard, Mark ;
Grillari, Johannes ;
Tauch, Andreas ;
Goesmann, Alexander ;
Helk, Bernhard ;
Mott, John E. ;
Puehler, Alfred ;
Borth, Nicole .
NATURE BIOTECHNOLOGY, 2013, 31 (08) :694-695
[7]   Structural origins of the functional divergence of human insulin-like growth factor-I and insulin [J].
Brzozowski, AM ;
Dodson, EJ ;
Dodson, GG ;
Murshudov, GN ;
Verma, C ;
Turkenburg, JP ;
de Bree, FM ;
Dauter, Z .
BIOCHEMISTRY, 2002, 41 (30) :9389-9397
[8]   Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer [J].
Clemmons, David R. .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (10) :821-833
[9]   Metabolic Actions of Insulin-Like Growth Factor-I in Normal Physiology and Diabetes [J].
Clemmons, David R. .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2012, 41 (02) :425-+
[10]   BAK and BAX Deletion Using Zinc-Finger Nucleases Yields Apoptosis-Resistant CHO Cells [J].
Cost, Gregory J. ;
Freyvert, Yevgeniy ;
Vafiadis, Annamaria ;
Santiago, Yolanda ;
Miller, Jeffrey C. ;
Rebar, Edward ;
Collingwood, Trevor N. ;
Snowden, Andrew ;
Gregory, Philip D. .
BIOTECHNOLOGY AND BIOENGINEERING, 2010, 105 (02) :330-340